Cargando…
Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma
Pet dogs develop spontaneous diffuse large B cell lymphoma (DLBCL), and veterinary clinical trials have been employed to treat canine DLBCL and to inform clinical trials for their human companions. A challenge that remains is selection of treatment to improve outcomes. The dogs in this study were pa...
Autores principales: | Dittrich, Katherine, Yıldız-Altay, Ümmügülsüm, Qutab, Fatima, Kwong, Danny A., Rao, Zechuan, Nievez-Lozano, Sebastian A., Gardner, Heather L., Richmond, Jillian M., London, Cheryl A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456153/ https://www.ncbi.nlm.nih.gov/pubmed/37624862 http://dx.doi.org/10.1371/journal.pone.0290428 |
Ejemplares similares
-
Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023) -
Characterizing the metabolic role of STAT3 in canine osteosarcoma
por: Gardner, Heather L., et al.
Publicado: (2022) -
Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia
por: Schuh, Elizabeth M., et al.
Publicado: (2017) -
MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022) -
ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
por: Cam, Maren, et al.
Publicado: (2016)